bromoperidol,
bromperidol,
bromperidol hydrochloride,
bromperidol, 82Br-labeled,
C-C 2489-21,
Impromen,
R 11,333,
Tesoprel,
bromperidol,
10457-90-6,
Impromen,
Bromoperidol,
Tesoprel,
Azurene,
UNII-LYH6F7I22E,
Bromperidolum [INN-Latin],
4-(4-(4-bromophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one,
R 11333,
EINECS 233-943-3,
4-(4-(4-Bromophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone,
CC 2489,
BRN 1552256,
LYH6F7I22E,
4-(4-(p-Bromophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone,
RKLNONIVDFXQRX-UHFFFAOYSA-N,
4-(4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone,
NCGC00016692-01,
4-(4-(p-Bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone,
CAS-10457-90-6,
DSSTox_CID_2690,
4-[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone,
4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,
BUTYROPHENONE, 4-(4-(p-BROMOPHENYL)-4-HYDROXYPIPERIDINO)-4'-FLUORO-,
1-Butanone, 4-(4-(4-bromophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-,
DSSTox_RID_76693,
DSSTox_GSID_22690,
Bromperidolum,
4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one,
1-Butanone, 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-,
4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone;4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone,
SR-05000001811,
C21H23BrFNO2,
4-[4-(p-bromophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone,
Impromen (TN),
Bromperidol [USAN:BAN:INN:JAN],
Bromperidol [USAN:INN:BAN:JAN],
Prestwick_781,
PubChem18557,
Prestwick0_000509,
Prestwick1_000509,
Prestwick2_000509,
Prestwick3_000509,
AC1L1DP8,
SCHEMBL43755,
BSPBio_000437,
5-21-02-00382 (Beilstein Handbook Reference),
MLS002153852,
CHEMBL28218,
R 11,333,
SPBio_002358,
Bromperidol (JAN/USAN/INN),
Azurene|||Tesoprel|||Impromen,
BPBio1_000481,
DTXSID0022690,
BDBM81484,
CHEBI:31305,
CTK7B9730,
HMS1569F19,
HMS2093J06,
HMS2096F19,
HMS2230O05,
HMS3370C12,
HMS3713F19,
Pharmakon1600-01505972,
ZINC601270,
CAS_2448,
HY-B0901,
NSC_2448,
Tox21_110565,
NSC759275,
PDSP1_001125,
PDSP2_001109,
AKOS015914052,
Tox21_110565_1,
API0001769,
CCG-213579,
DB12401,
NSC-759275,
NCGC00016692-02,
NCGC00016692-05,
NCGC00179558-01,
AJ-23670,
BC004382,
CC-25252,
LS-48293,
SMR001233211,
SBI-0206864.P001,
AX8118878,
FT-0630383,
D01101,
C-22059,
L000662,
R-11333,
J-001195,
SR-05000001811-1,
SR-05000001811-3,
BRD-K78643075-001-03-3,
BRD-K78643075-001-06-6,
I14-44656,
Bromperidol, European Pharmacopoeia (EP) Reference Standard,
4-[4-(p-Bromophenyl)-4-hydroxypiperidino]-4'-fluoro-butyrophenone,
1-Butanone, 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-,
4-[4-(4-Bromo-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one,
4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one,
bromperidol HCl,
bromperidol hydrochloride,
bromperidol, 82Br-labeled,
D00SHQ,
CID2448,
C21-H23-Br-F-N-O2,
CS-4366,
C-C 2489-21,
C006820,
Butyrophenone, 4-[4-(p-bromophenyl)-4-hydroxypiperidino]-4'-fluoro-,
14146-26-0,